BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Conference: 15 – 16 March 2021Virtual Conference: Online Acces s Only  \;Website: \;\n\nChaired by: Darren Green\, Director of M olecular Design &\; Senior Fellow\, GSK\n\nSponsored by: OpenEye Scien tific Software\n\n \;\n\nSMi is proud to present its 2nd Annual AI in Drug Discovery Conference\, taking place on the 15-16 March 2021.\n\nWit h the global Artificial Intelligence (AI) in Drug Discovery Market size e xpected to exceed $3\,900 million by 2027\, the conference agenda will en compass key drivers leading the way into a shorter\, cheaper\, and more s uccessful R&\;D era. The conference will be a particular focus on case studies from leading pharma and biotech\, as well as a close-up view on the paradigm shift from undruggable targets to ‘challenging to drug’.&nbs p\;Furthermore the event will focus on 4 key themes: machine learning and automation for improved drug discovery pipelines\; effective prediction of compound properties\; data robustness and curation\; innovative use of AI for rare and undruggable diseases\, and will highlight key case studi es across these themes\, uncovering key developments in pharma of data op timization and to aid therapeutic discovery. Real-world examples of AI in structure-based drug design and patient relevant data will be explored i n eye-opening detail\n\nEvent Hashtag: #SMiAIDrugDis\n\nHIGHLIGHTS FOR 20 21 INCLUDE:• Discover the latest innovations in AI-based drug discovery p latforms• Engage in case study presentations from leading pharma and biot ech companies on machine learning and improved drug discovery pipelines• Understand how AI can be effectively implemented to enhance productivity• Delve into best practices in data quality\, curation\, and validation• E xplore how AI is being used to unlock therapies that have evaded traditio nal drug discovery\n\nKEY SPEAKERS INCLUDE• Noor Shaker\, CEO\, Glamorous AI• Maria Luisa Pineda\, Co-Founder &\; CEO\, Envisagenics• Ed Addiso n\, Co-founder\, Chairman\, and CEO\, Cloud Pharmaceuticals• Liling Warre n\, Director\, Head of Translational Medicine Statistics\, Teva Pharmaceu ticals• Lili Peng\, Associate Director Scientific Ecosystem Analytics Lea d\, Biogen• Mark De Pristo\, CEO\, BigHat Biosciences• Philipe Moingeon\, Head of Immuno-inflammation\, Servier \;• Hugo Ceulemans\, Scientifi c Director\, Discovery Data Sciences\, Janssen• Peter Henstock\, Machine Learning &\; AI Lead\, Pfizer• Naheed Kurji\, CEO\, Cyclica\n\nWHO SHO ULD ATTENDCEOs\, Presidents\, Vice Presidents and Global Heads\, Executiv e Directors\, Vice President &\; Global head\, Principal Scientists\, Heads of Business Development\, Directors of Pharma/Biotech firms.\n DTEND:20210316T170000 DTSTAMP:20260512T230904Z DTSTART:20210315T090000 LOCATION:India House\, SMi Group\, India House\, Curlew Street\, London\, London\, SE1 2ND\, SEQUENCE:0 SUMMARY:Conference: 15 – 16 March 2021Virtual Conference: Online Access On ly  \;Website: \;\nChaired by: Darren Green\, Director of Molecul ar Design &... UID:5a2f1307-0eab-4840-b35b-0ea1721e0264 END:VEVENT END:VCALENDAR